Vanessa Pereira Mendes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vanessa Pereira Mendes has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aline da Silva Goulart
Universidade Federal do Rio Grande do Sul - Porto Alegre - Rio Grande do Sul - Brasil
1 shared publication - Andréia Caroline Fernandes Salgueiro
Universidade Estadual do Norte do Paraná - UENP
1 shared publication - Bruno Leite Anjos
Universidade Federal do Pampa (UNIPAMPA), Brasil; Universidade Federal do Pampa (UNIPAMPA), Brasil
1 shared publication - Eloá Ferreira Yamada
Universidade Federal do Pampa (UNIPAMPA)
1 shared publication - Morgana Duarte da Silva
Program of Post-graduation in Neuroscience, Universidade Federal de Santa Catarina (UFSC) , Florianópolis, Santa Catarina
1 shared publication - Vanderlei Folmer
UniPampa
1 shared publication
Latest Publications
- 25 December 2018
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 22 (3) , 399-410
Evaluation of monosodium iodoacetate dosage to induce knee osteoarthritis: Relation with oxidative stress and pain
Aim: To determine the dose of monosodium iodoacetate (MIA) required to induce oxidative stress, as well as pain and edema; to confirm the induction of knee osteoarthritis (OA) symptoms in rats by the presence of reactive oxygen species (ROS) and reduction of antioxidant agents; and to verify the presence of histopathological injury in these affected joints. Method: Biological markers of oxidative stress, pain, knee edema, and cartilage degeneration provided by different doses of MIA (0.5; 1.0 or 1.5 mg) in rat knee joints were analyzed. The animal evaluations were conducted during 15 days for mechanical and cold hypersensitivity, spontaneous pain and edema. After that, blood serum, intra‐articular lavage and structures of knee, spinal cord and brainstem were collected for biochemical analysis; moreover, the knees were removed for histological evaluation. Results: This study demonstrates that the highest dose of MIA (1.5 mg) increased the oxidative stress markers and reduced the antioxidant reactions, both in the focus of the lesion and in distant sites. MIA also induced the inflammatory process, characterized by pain, edema, increase in neutrophil count and articular damage. Conclusion: This model provides a basis for the exploration of underlying mechanisms in OA and the identification of mechanisms that may guide therapy and the discovery of OA signals and symptoms.
- 25 December 2018
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 22 (3) , 399-410
Evaluation of monosodium iodoacetate dosage to induce knee osteoarthritis: Relation with oxidative stress and pain
Aim: To determine the dose of monosodium iodoacetate (MIA) required to induce oxidative stress, as well as pain and edema; to confirm the induction of knee osteoarthritis (OA) symptoms in rats by the presence of reactive oxygen species (ROS) and reduction of antioxidant agents; and to verify the presence of histopathological injury in these affected joints. Method: Biological markers of oxidative stress, pain, knee edema, and cartilage degeneration provided by different doses of MIA (0.5; 1.0 or 1.5 mg) in rat knee joints were analyzed. The animal evaluations were conducted during 15 days for mechanical and cold hypersensitivity, spontaneous pain and edema. After that, blood serum, intra‐articular lavage and structures of knee, spinal cord and brainstem were collected for biochemical analysis; moreover, the knees were removed for histological evaluation. Results: This study demonstrates that the highest dose of MIA (1.5 mg) increased the oxidative stress markers and reduced the antioxidant reactions, both in the focus of the lesion and in distant sites. MIA also induced the inflammatory process, characterized by pain, edema, increase in neutrophil count and articular damage. Conclusion: This model provides a basis for the exploration of underlying mechanisms in OA and the identification of mechanisms that may guide therapy and the discovery of OA signals and symptoms.